MSH2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.955200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.595000E-01
Normal-vs-Stage2
4.422200E-01
Normal-vs-Stage3
3.096200E-02
Normal-vs-Stage4
8.280800E-01
Stage1-vs-Stage2
8.713400E-01
Stage1-vs-Stage3
4.647900E-02
Stage1-vs-Stage4
2.691800E-01
Stage2-vs-Stage3
8.223100E-04
Stage2-vs-Stage4
2.085800E-01
Stage3-vs-Stage4
9.118100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.387400E-01
Normal-vs-AfricanAmerican
6.113400E-01
Normal-vs-Asian
5.244100E-02
Caucasian-vs-AfricanAmerican
8.704200E-01
Caucasian-vs-Asian
1.323180E-01
AfricanAmerican-vs-Asian
2.001400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.980200E-01
Normal-vs-Female
5.152200E-01
Male-vs-Female
4.589200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.646390E-01
Normal-vs-Age(41-60Yrs)
7.229200E-01
Normal-vs-Age(61-80Yrs)
2.489000E-01
Normal-vs-Age(81-100Yrs)
3.885400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.766800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.347200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.815200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.227900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.462200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.098200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.201800E-01
Normal-vs-Daily Drinker
4.296600E-01
Normal-vs-Weekly Drinker
7.513700E-02
Normal-vs-Occasional Drinker
5.849400E-01
Normal-vs-Social Drinker
5.661400E-01
Non Drinker-vs-Daily Drinker
9.744200E-01
Non Drinker-vs-Weekly Drinker
2.808400E-01
Non Drinker-vs-Occasional Drinker
3.644400E-01
Non Drinker-vs-Social Drinker
7.648400E-01
Daily Drinker-vs-Weekly Drinker
2.763200E-01
Daily Drinker-vs-Occasional Drinker
3.663600E-01
Daily Drinker-vs-Social Drinker
7.591200E-01
Weekly Drinker-vs-Occasional Drinker
1.787830E-02
Weekly Drinker-vs-Social Drinker
1.918210E-01
Occasional Drinker-vs-Social Drinker
6.329400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.402800E-01
Normal-vs-Grade 2
7.876000E-01
Normal-vs-Grade 3
3.897400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.091800E-02
Grade 1-vs-Grade 3
5.703400E-03
Grade 1-vs-Grade 4
9.402800E-01
Grade 2-vs-Grade 3
1.687390E-01
Grade 2-vs-Grade 4
7.876000E-01
Grade 3-vs-Grade 4
3.897400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.363200E-01
Normal-vs-NonDiabetic
3.457000E-01
Diabetic-vs-NonDiabetic
8.178800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.954190E-01
Normal-vs-NoPancreatitis
3.878400E-01
Pancreatitis-vs-NoPancreatitis
6.471000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.872400E-01
Normal-vs-N1
4.695600E-01
N0-vs-N1
5.982200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.530400E-01
Normal-vs-TP53-NonMutant
2.697200E-01
TP53-Mutant-vs-TP53-NonMutant
1.241810E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
